Literature DB >> 15932212

A new fluorogenic transformation: development of an optical probe for coenzyme Q.

Matthew S Tremblay1, Dalibor Sames.   

Abstract

[reaction: see text] A new fluorogenic transformation based on a quinone reduction/lactonization sequence has been developed and evaluated as a tool for probing redox phenomena in a biochemical context. The probe presented herein is an irreversible redox probe and is reduced selectively by biologically relevant quinols such as ubiquinol but is inert to reduced nicotinamides (e.g., NADH). The ensuing cyclization is fast and quantitative and provides a measurable optical response.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15932212     DOI: 10.1021/ol0507569

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  4 in total

1.  Visible-to-NIR-Light Activated Release: From Small Molecules to Nanomaterials.

Authors:  Roy Weinstain; Tomáš Slanina; Dnyaneshwar Kand; Petr Klán
Journal:  Chem Rev       Date:  2020-10-30       Impact factor: 60.622

2.  Role of the multifunctional DNA repair and redox signaling protein Ape1/Ref-1 in cancer and endothelial cells: small-molecule inhibition of the redox function of Ape1.

Authors:  Meihua Luo; Sarah Delaplane; Aihua Jiang; April Reed; Ying He; Melissa Fishel; Rodney L Nyland; Richard F Borch; Xiaoxi Qiao; Millie M Georgiadis; Mark R Kelley
Journal:  Antioxid Redox Signal       Date:  2008-11       Impact factor: 8.401

3.  Design and synthesis of novel quinone inhibitors targeted to the redox function of apurinic/apyrimidinic endonuclease 1/redox enhancing factor-1 (Ape1/ref-1).

Authors:  Rodney L Nyland; Meihua Luo; Mark R Kelley; Richard F Borch
Journal:  J Med Chem       Date:  2010-02-11       Impact factor: 7.446

4.  Studies toward the Development of Antiproliferative Neoclerodanes from Salvinorin A.

Authors:  Tamara Vasiljevik; Chad E Groer; Kurt Lehner; Hernan Navarro; Thomas E Prisinzano
Journal:  J Nat Prod       Date:  2014-07-30       Impact factor: 4.050

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.